Godavari Drugs

95.35
-1.54
(-1.59%)
Market Cap
71.84 Cr
EPS
7.37
PE Ratio
11.80
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
155.00
52 Week Low
79.00
PB Ratio
1.75
Debt to Equity
1.29
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,751.50
#1 4,20,243.52
34.43
#1 49,887.20
12.06
#1 9,648
13.77
56.15
5,640.00
1,49,724.28
73.95
8,184.00
0.89
1,600
#1 64.53
49.32
1,515.20
1,22,369.82
24.22
26,520.70
14.17
4,155
47.38
58.14
3,254.80
1,10,157.22
58.55
10,785.70
11.59
1,656
13.54
57.00
2,581.60
1,06,511.27
50.98
10,615.60
19.57
1,942
-16.38
65.51
1,163.60
97,097.23
#1 18.01
28,905.40
12.36
5,578
1.69
53.92
1,937.20
88,441.11
30.81
20,141.50
#1 19.94
1,936
38.82
44.61
831.55
83,673.39
18.24
19,831.50
13.82
3,831
29.92
39.09
1,171.60
68,046.72
18.66
29,559.20
17.55
3,169
-10.04
56.33
30,690.00
65,214.11
48.91
6,097.20
10.80
1,201
16.01
56.24
Growth Rate
Revenue Growth
-1.87 %
Net Income Growth
44.74 %
Cash Flow Change
39.26 %
ROE
25.68 %
ROCE
20.84 %
EBITDA Margin (Avg.)
34.09 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
TTM
Revenue
55
71
76
65
84
96
123
161
160
157
128
Expenses
49
67
70
60
78
90
113
150
150
143
113
EBITDA
6
5
6
5
6
6
10
12
11
14
14
Operating Profit %
11 %
6 %
7 %
6 %
7 %
6 %
8 %
7 %
6 %
8 %
10 %
Depreciation
1
1
1
1
1
1
1
2
2
2
2
Interest
1
2
3
2
3
3
3
3
4
5
5
Profit Before Tax
5
2
3
1
2
2
6
7
5
7
7
Tax
1
1
1
1
1
0
2
2
1
1
1
Net Profit
4
1
2
1
1
2
4
5
4
6
6
EPS in ₹
4.84
1.79
2.40
1.10
1.60
2.66
5.48
6.97
5.03
7.37
8.20

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
35
51
56
63
74
84
91
101
121
135
Fixed Assets
7
9
13
15
15
14
22
26
25
27
Current Assets
27
40
43
47
57
61
68
74
87
89
Capital Work in Progress
0
1
0
1
2
9
1
1
9
18
Investments
0
0
0
0
0
0
0
0
0
0
Other Assets
27
41
43
48
57
61
68
75
87
90
Total Liabilities
35
51
56
63
74
84
91
101
121
135
Current Liabilities
17
31
34
37
46
51
51
58
74
82
Non Current Liabilities
5
5
6
9
9
12
16
14
14
14
Total Equity
13
14
16
17
18
20
24
30
33
39
Reserve & Surplus
6
7
9
10
11
13
17
22
26
31
Share Capital
8
8
8
8
8
8
8
8
8
8

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
0
0
0
1
-0
-0
0
1
1
-1
Investing Activities
-0
-2
-3
-3
-2
-7
-1
-5
-9
-13
Operating Activities
-6
-5
5
4
4
6
1
11
13
18
Financing Activities
6
7
-2
-0
-2
0
0
-6
-4
-6

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
55.86 %
56.13 %
56.13 %
56.13 %
56.36 %
56.92 %
56.92 %
53.12 %
53.12 %
53.16 %
53.16 %
53.16 %
53.16 %
53.16 %
52.63 %
52.63 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.50 %
0.50 %
0.50 %
0.50 %
0.50 %
0.50 %
0.50 %
0.50 %
0.50 %
0.50 %
0.50 %
0.50 %
0.50 %
0.50 %
0.50 %
0.50 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
36.16 %
36.05 %
36.33 %
36.14 %
35.59 %
35.87 %
35.90 %
39.27 %
7.27 %
38.75 %
38.99 %
38.87 %
39.10 %
38.96 %
39.76 %
39.98 %
Others
7.49 %
7.32 %
7.05 %
7.23 %
7.56 %
6.71 %
6.68 %
7.12 %
39.11 %
7.59 %
7.35 %
7.47 %
7.24 %
7.38 %
7.11 %
6.89 %
No of Share Holders
0
4,136
4,567
5,394
5,750
6,034
6,232
5,968
6,555
6,561
7,019
6,894
7,005
7,044
7,709
7,915

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Corporate Action

Announcements

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 20184 days ago
Closure of Trading WindowMar 27, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 13, 2025
Integrated Filing (Financial)Feb 12, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Of Godavari Drugs Limited (The Company) Held On Wednesday 12Th February 2025Feb 12, 2025
Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2024Feb 12, 2025
Board Meeting Intimation for Intimation Of The Board Meeting Of Godavari Drugs Limited (The Company) To Be Held On Wednesday February 12 2025.Feb 06, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 20, 2025
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateJan 02, 2025
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateDec 31, 2024
Closure of Trading WindowDec 31, 2024
Submission Of Revised Certificate Under Regulation 40(10) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations 2015) For The Financial Year Ended 31Dec 23, 2024
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 15, 2024
Unaudited Financial Results For Quarter And Half-Year Ended September 30, 2024Nov 14, 2024
Board Meeting Outcome for Outcome Of The Board Meeting Of Godavari Drugs Limited (The Company) Held On Thursday 14Th November, 2024Nov 14, 2024
Board Meeting Intimation for Intimation For Board MeetingNov 08, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 15, 2024
Closure of Trading WindowSep 30, 2024
Reg. 34 (1) Annual Report.Sep 05, 2024
Shareholder Meeting / Postal Ballot-Scrutinizer''''s ReportSep 02, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGMAug 29, 2024
Clarification On Share Price MovementAug 29, 2024
Clarification Sought from Godavari Drugs LtdAug 28, 2024
Un-Audited Financial Results For The Quarter Ended On 30.06.2024Aug 14, 2024
Board Meeting Intimation for Un-Audited Financial Results For The Quarter Ended On 30.06.2024Aug 09, 2024
Newspaper Advertisement Titled 'Notice Of The 36Th Annual General Meeting And E-Voting Information'Aug 09, 2024
Newspaper Advertisement Titled 'Notice Of The 36Th Annual General Meeting And E-Voting Information'Aug 09, 2024
Notice Convening 36Th Annual General Meeting (AGM)Aug 05, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Jul 12, 2024
Closure of Trading WindowJun 26, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 31, 2024
Financial Results For The Quarter And Year Ended On 31St March 2024May 30, 2024
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 30, 2024
Board Meeting Outcome for Outcome Of Board MeetingMay 30, 2024
Board Meeting Intimation for To Consider And Approve Audited Financial Results/Statements For The Quarter And Year Ended On 31St March 2024May 24, 2024
Compliance Certificate For The Period Ended 31St March, 2024 In Terms Of Regulation 7(3) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015Apr 29, 2024
Submission Of Certificate Under Regulation 40(10) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 (SEBI Listing Regulations, 2015) For The Financial Year Ended 31 March 2024Apr 29, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Apr 16, 2024
Closure of Trading WindowMar 30, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 14, 2024
Submission Of Un-Audited Financial Results Of The Company For The Quarter Ended 31St December, 2023 And Limited Review Report As Per The Provisions Of Regulation 33 Of SEBI (LODR) Regulations, 2015Feb 13, 2024
Board Meeting Outcome for Outcome Of The Board MeetingFeb 13, 2024
Update on board meetingFeb 07, 2024
Board Meeting Intimation for The Board Meeting Of Godavari Drugs Limited (The 'Company') To Be Held On Wednesday, February 14, 2024.Feb 06, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Jan 19, 2024
Closure of Trading WindowDec 30, 2023
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 15, 2023
Regarding Lease Of Land In Kushnoor Industrial Area, Nanded MaharastraNov 15, 2023
Unaudited Financial Results For Quarter And Half Year Ended Sep 30, 2023Nov 14, 2023
Board Meeting Outcome for Godavari Drugs Limited (The ''Company'') Held On Tuesday, November 14, 2023Nov 14, 2023

Technical Indicators

RSI(14)
Neutral
52.26
ATR(14)
Less Volatile
5.24
STOCH(9,6)
Neutral
59.88
STOCH RSI(14)
Overbought
80.23
MACD(12,26)
Bullish
0.42
ADX(14)
Weak Trend
9.51
UO(9)
Bearish
44.78
ROC(12)
Uptrend And Accelerating
6.36
WillR(14)
Neutral
-28.43